KSS
Kohl's Corporation
KSS trails on the overall score without a compensating advantage in the available component scores.
LCID
Lucid Group, Inc.
LCID has a slight edge over KSS overall, supported by stronger valuation and stronger modeled upside.
KSS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
KSS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
KSS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.1x | $14.11 | -40% |
| Fair | 8.2x | $18.88 | -20% |
| Current | 10x | $23.50 | — |
| Expensive | 11x | $26.18 | +11% |
Historical ranges are pointers, not guarantees.
KSS's PE is in its expensive range at 10x.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
KSS Forward outlook
There aren't enough analyst estimates for KSS to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
KSS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.31 | +25% |
| Q2 2026 | $2.38 | +118% |
| Q1 2026 | $2.38 | +143% |
| Q4 2025 | $1.72 | -23% |
| Q3 2025 | $1.85 | -27% |
| Q2 2025 | $1.09 | -56% |
| Q1 2025 | $0.98 | -66% |
| Q4 2024 | $2.22 | +$3.23 |
KSS has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
KSS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.5B | -0.9% |
| Q2 2026 | $3.2B | -2% |
| Q1 2026 | $5.2B | -4.2% |
| Q4 2025 | $3.6B | -3.6% |
| Q3 2025 | $3.5B | -5% |
| Q2 2025 | $3.2B | -4.4% |
| Q1 2025 | $5.4B | -9.4% |
| Q4 2024 | $3.7B | -8.5% |
KSS's revenue fell from its 2020 peak and has held roughly level since: $3.5B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.4% | -0.4 points |
| Q2 2026 | 1.4% | -0.4 points |
| Q1 2026 | 4.1% | +1.8 points |
| Q4 2025 | 2% | -0.6 points |
| Q3 2025 | 7.9% | +3.4 points |
| Q2 2025 | 1.9% | +0.6 points |
| Q1 2025 | 2.3% | -2.7 points |
| Q4 2024 | 2.6% | -1.2 points |
KSS has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over KSS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
KSS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $490M | -3.5% |
| Q2 2026 | -$158M | +$44M |
| Q1 2026 | $686M | +38% |
| Q4 2025 | $16M | +$339M |
| Q3 2025 | $508M | +260% |
| Q2 2025 | -$202M | -$69M |
| Q1 2025 | $497M | -30% |
| Q4 2024 | -$323M | -$317M |
KSS has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
KSS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.4% | +6M shares |
| 1 year | +3.5% | +4M shares |
| 3 years | +6.3% | +7M shares |
| 5 years | -24% | -38M shares |
| Available history | -25% | -39M shares |
KSS has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2023 | — |
| Q4 2022 | $500M |
| Q3 2022 | — |
| Q2 2022 | $158M |
| Q1 2022 | $548M |
| Q4 2021 | $506M |
| Q3 2021 | $255M |
| Q2 2021 | $46M |
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
KSS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.4x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 1.1x | Healthy |
| Q3 2025 | 1.1x | Healthy |
| Q2 2025 | 1.2x | Healthy |
| Q1 2025 | 1.2x | Healthy |
| Q4 2024 | 1.0x | Healthy |
KSS's net debt is less than a year of its operating earnings (EBITDA), down from 1.1 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
KSS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.0 | Neutral |
| Stochastic | 80.9 | Overbought |
KSS's weekly RSI is 64 (neutral) and its Stochastic is 81 (overbought).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
KSS PE vs Consumer Cyclical Sector
| Metric | KSS | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 18x | 44% below |
| PE % | 75 | 47 | 28 pts above |
KSS is trading at 10x earnings, a 44% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
KSS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.8 | 8% above |
| 20 week MA | $19.5 | 20% above |
| 50 week MA | $18.0 | 31% above |
| 100 week MA | $15.0 | 57% above |
| 200 week MA | $19.2 | 22% above |
KSS has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
KSS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $50.9 | $38.9 | -24% |
| 2021 | $38.9 | $50.2 | +29% |
| 2022 | $50.2 | $25.0 | -50% |
| 2023 | $25.0 | $28.7 | +15% |
| 2024 | $28.7 | $14.4 | -50% |
| 2025 | $14.4 | $21.6 | +50% |
| 2026 YTD | $21.6 | $23.5 | +8.9% |
KSS has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.